EASL Members: Request your free copy of the EASL history book
On 20 July 2010, the European Commission Directorate General for Research published the 2011 Health Work Programme of the Seventh Framework Programme for research and technological development (FP7)
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide... Read more
Abstract info

Participants to the International Liver Congress 2010 submitted abstracts on the categories listed below. All accepted abstracts were to be published in the Journal of Hepatology and if selected, either the principal author or someone from his/her group was requested to present the abstract.

Abstracts presented in previous international Gastroenterology/Hepatology meetings were NOT accepted.

Note: After submission, all abstracts are viewed anonymously by experts and are scored according to their merit. Thereafter, abstracts are selected for oral or poster presentations by the EASL Scientific Committee.

Abstract categories for the International Liver Congress™ 2011 will shortly be available


List of abstract categories 2010

CATEGORY/TITLE
1a    Liver transplantation, surgery : Experimental
1b    Liver transplantation: Clinical
1c    Liver transplantation, surgery: Acute liver failure-Clinical & Experimental
2a    Cirrhosis and its complications: Pathophysiology
2b    Cirrhosis and its complications: Clinical aspects
2c    Cirrhosis and its complications: Bleeding
2d    Cirrhosis and its complications: Hepatorinal syndrome and ascitis
3a    Liver Tumors Experimental
3b    Liver Tumors  Clinical  (epidemiology, diagnosis)
3c    Liver Tumors : Management
4a    Molecular and cellular biology: Cell cycle control / apoptosis
4b    Molecular and cellular biology: Biliary tract pathophysiology
4c    Molecular and cellular biology: HSCs and fibrosis
4d    Molecular and cellular biology: Liver regeneration
5a    Viral hepatitis: Hepatitis B - Experimental
5b    Viral hepatitis: Hepatitis C – Experimental (virology)
5c    Viral hepatitis: Hepatitis C – Experimental (immunology)
5d    Viral hepatitis: Hepatitis B – clinical (Except Therapy)
5e    Viral hepatitis: Hepatitis B – clinical (Therapy, new compounds, resistance)
5f     Viral hepatitis: Hepatitis C – clinical (Except Therapy)
5g    Viral hepatitis: Hepatitis C – clinical (Therapy)
5h    Viral hepatitis: Hepatitis C – clinical (new compounds, resistance)
5i     Viral Hepatitis: Hepatitis A , D and E
6      Autoimmune and chronic cholestatic liver diseases
7      Pediatric Hepatology - Inherited diseases of the liver
8a    Alcoholic drug induced and fatty liver disease: Experimental
8b    Alcoholic drug induced and fatty liver disease: Clinical
8c    Alcoholic drug induced and fatty liver disease: NAFLD /NASH – Clinical
9      Miscellaneous




1a
Liver ransplantation, surgery, acute liver failure - Experimental
1b Liver transplantation, surgery, acute liver failure - Clinical
2a
Cirrhosis and its complications: Pathophysiology
2b
Cirrhosis and its complications: Clinical aspects
3a
Livers Tumors Experimental
3b
Livers Tumors Clinical (epidemiology, diagnosis, management)
4a
Molecular and cellular biology: Cell cycle control / apoptosis
4b
Molecular and cellular biology: Biliary tract pathophysiology
4c
Molecular and cellular biology: HSCs and fibrosis
4d Molecular and cellular biology: Liver regeneration
4e Molecular and cellular biology: Gene transfer / Gene therapy
5a Viral hepatitis: Hepatitis B - Experimental
5b
Viral hepatitis: Hepatitis C - Experimental (virology)
5c
Viral hepatitis: Hepatitis C - Experimental (immunology)
5d Viral hepatitis: Hepatitis B - Clinical (except therapy)
5e Viral hepatitis: Hepatitis B - (Therapy, new compounds, resistance)
5f
Viral hepatitis: Hepatitis C - Clinical (except therapy)
5g
Viral hepatitis: Hepatitis C - Clinical (therapy)
5h
Viral hepatitis: Hepatitis C - (new compounds, resistance)
6 Autoimmune and chronic cholestatic liver disease
7 Pediatric Hepatology - Inherited diseases of the liver
8a Alcoholic liver disease, NAFLD and drug induced liver disease - Experimental
8b
Alcoholic liver disease, NAFLD and drug induced liver disease - Clinical